Bioulvax SA
Bioulvax reported total assets of €1.53m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
By total assets for 2025, Bioulvax ranks among the 100 largest of the 801 companies in its sector (NACE 4725) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Bioulvax shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -34 % Total assets -16 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bioulvax's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 31 Dec 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Bioulvax's financial analysis
- Solvency49.2%sector median: 29.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bioulvax
Bioulvax's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0435.522.971
- VAT number
- BE0435522971
- Peppol
- Registered · 0208:0435522971 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 03 Oct 1988
- Registered office
- 5537 Anhée
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of wine and spirits (NACE 47251)
Bioulvax (SA) has been based in Anhée since 1988, active in: retail sale of wine and spirits. For 2025, it reports a net loss of 87,521 € and equity of 752,943 €; its revenue is not published. Its solvency stands at 49.2%, above the median of its sector (29.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Bioulvax
Companies in the same business, of comparable size and area, outside its group.
- Topolino Manufacture of wine from grape Sint-Niklaas · balance sheet 598,138 €
- VMCO Activities of head offices Kuurne · balance sheet €1.31m
- Intersolution Activities of head offices Vosselaar · balance sheet 322,092 €
- BJ Gestion et Investissement Retail sale of beverages Montigny-le-Tilleul · balance sheet €1.89m
- Feyaerts Invest Retail sale of beverages Vilvoorde · balance sheet €1.38m
- A Wide Hub Retail sale of beverages Lasne · balance sheet 467,442 €
- Vins Rares et Pépites Retail sale of beverages Mons · balance sheet 607,077 €
- Wijnen Vanassche Wholesale of beverages Ingelmunster · balance sheet €1.17m
Frequently asked questions about Bioulvax
What is the revenue of Bioulvax?
Bioulvax files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bioulvax?
In Belgium, the VAT number is the company number prefixed with BE: BE0435522971 for Bioulvax, if the company is VAT-registered. Its company number (CBE) is 0435.522.971.
Where is the registered office of Bioulvax?
According to the CBE register, the registered office of Bioulvax is in 5537 Anhée.
What is the equity of Bioulvax?
At the close of the 2025 financial year, the equity of Bioulvax amounts to 752,943 €, a solvency of 49.2% of total assets.
Who manages Bioulvax?
The register lists 3 active mandates at Bioulvax. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Bioulvax within its sector?
By total assets for 2025, Bioulvax ranks among the 100 largest of the 801 companies in its sector (NACE 4725) in Belgium that filed accounts for that financial year.
The full file of Bioulvax
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →